Genu Recurvatum Market

Genu Recurvatum Market Outlook (2023 to 2033)

The global genu recurvatum market size is valued at US$ 6.9 billion in 2023. Global revenue from genu recurvatum treatment is predicted to rise at a CAGR of 5.6% and reach a market valuation of US$ 12 billion by the end of 2033.

The market for genu recurvatum is anticipated to progress owing to the rising population of elderly people around the world. Senior citizens are more prone to orthopedic disorders due to weakness in their bones with increasing age.

• According to the World Health Organization, the population of elderly people who are of 60 years or more is expected to reach one in six people by the end of 2030.

Genu recurvatum, an orthopedic complication with hyperextension of the knee, is very rare among people. Further, it is also known as knee hyperextension or back knee. Women are more prone to this disorder compared to men. It is identified in 0.5% to 1% of people, who need to undergo total knee arthroplasty (TKA).

The condition causes stress in the structure of the posterior knee, which can cause permanent damage to the joint. Knee osteoarthritis or knee pain are some other conditions, which are caused due to genu recurvatum. It can be severe, moderate, or mild. Bone deformities, plantar foot flexion, paralysis, quadriceps, and high tibial osteotomies are some other medical conditions, which can lead to genu recurvatum.

Genu recurvatum can be acquired or congenital, polio, prolonged casting, cerebrovascular accident, physical arrest, and Osgood-Schlatter disease can also lead to this disorder. It is a very rare condition, which is related to different malformations, including high dysplasia, talipes, and absent patella. Symptoms and signs of this medical disorder include pain in the outer back portion of the knee, pain in the inner-leg portion of the knee (medial tibiofemoral joint), difficulty in performing endurance activities, and extension of the gait pattern.

High requirements for treatment along with rising R&D activities in the healthcare industry are also expected to contribute to market growth opportunities. High need to provide more effective genu recurvatum diagnosis and treatment is predicted to contribute to market growth over the coming decade.

Fact.MR, a market research and competitive intelligence provider, offers a comprehensive analysis of the global industry. The newly published research report by the company provides detailed information about key market trends, competitive landscape, growth opportunities, regional overview, and other aspects.

Report Attributes	Details
Market Size in 2023	US$ 6.9 Billion
Forecasted Market Value (2033)	US$ 12 Billion
Global Market Growth Rate (2023 to 2033)	5.6% CAGR
Prominent Regional Market	North America
Key Companies Profiled	DePuy Synthes Companies Globus Medical, Inc. Medtronic Plc NuVasive, Inc. Smith & Nephew Plc Zimmer Inc. Stryker Corporation

Which Aspects are Driving Genu Recurvatum Market Growth?

“Growing Demand for Standard Remedial Solutions for Orthopedic Conditions”

Genu recurvatum is of three types, which are internal rotatory deformity (ERD), non-rotatory deformity (NRD), and internal rotatory deformity (IRD). Among these, NRD and ERD are more severe as they can lead to soft tissue damage. In underdeveloped and developing regions, the burden of orthopedic disorders is increasing owing to a lack of awareness.

• According to the IJO (Indian Journal of Orthopedics), poor education and improper orthopedic services, including poorly trained physicians handling musculoskeletal emergencies, poor surgeon-patient ratio, and absence of standard orthopedic care were observed in certain parts of India. The Indian Orthopedic Association (IOA) in collaboration with medical educationists, individual medical practitioners, and government health planners is taking initiatives to find remedial solutions to genu recurvatum.

What is Expected to Restrict Demand for Genu Recurvatum Treatment?

“Lack of Advanced Healthcare Infrastructure in Low- and Middle-Income Countries”

Low- and middle-income countries, around the world, do not have advanced healthcare facilities for the treatment of patients. So, the absence of well-established healthcare infrastructure is expected to negatively affect the demand for genu recurvatum treatment solutions.

“High Cost of Genu Recurvatum Treatment”

The high cost of treatment and management of genu recurvatum and similar disorders makes it impossible for people from lower income groups to afford these solutions. Therefore, demand for treatment solutions is impacted adversely.

How are Start-ups Anticipated to Change the Genu Recurvatum Landscape?

“Product Development – Unleashing New Avenues to Orthopedic Solutions”

New entrants in the global market need to invest a significant amount in extensive R&D activities to develop more effective genu recurvatum treatments. The currently available treatments are costly, so it becomes impossible for lower and middle-income countries to access them. New entrants need to explore all possible treatment options, which can be offered to patients.

Certain precautionary guidelines about genu recurvatum are being offered to avoid severe implications of this disorder. Different campaigns to increase awareness about this disorder and different treatment options, including physical therapy, bracing, surgical treatment, etc., are also being conducted by startups. Thus, the adoption of various strategies, including product launches, innovations, and others by new players is anticipated to contribute to market growth opportunities.

Why are Industry Players Investing in North America?

“Growing Participation of Industry Players in Advancements of Treatment Approaches”

North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa are the prominent regional areas, which are expected to contribute to global market revenue. Among these, North America is anticipated to hold a dominating position in the target industry over the forecast period.

Increasing expenditure in healthcare and rising health consciousness among several people are predicted to contribute to opportunities for genu recurvatum market players. In addition, the growing participation of new players and prominent players in advancement approaches for genu recurvatum treatment is also expected to fuel growth in the target market.

Country-wise Insights

How are Suppliers of Genu Recurvatum Treatment Solutions Benefiting from the United States Market?

“Rising Prevalence of Chronic Disorders among Americans”

Americans are ready to invest a significant amount in advanced healthcare facilities. Moreover, increasing awareness about genu recurvatum treatment options in the United States is anticipated to contribute to lucrative growth opportunities over the coming decade.

• As per data provided by CDC (Centers for Disease Control and Prevention), a significant share of the total annual healthcare expenditure in the United States is reserved for people with chronic conditions. This share is around 85% of the annual healthcare expenditure in the United States.

Why is Germany Expected to Offer Rewarding Market Growth Opportunities?

“Improved Reimbursement Policies in Healthcare Sector”

Germany is predicted to hold a noticeable share of the European market revenue over the forecasted period due to improvements in reimbursement policies and schemes in the healthcare sector. Moreover, support from government bodies to conduct R&D activities for more effective genu recurvatum treatment solutions is also expected to drive market growth.

Category-wise Insights

Which Types of Genu Recurvatum are Commonly Diagnosed among Patients?

“NRD and ERD – Commonly Identified Types of Genu Recurvatum”

External rotatory deformity (ERD), non-rotatory deformity (NRD), and internal rotatory deformity (IRD) are three types of genu recurvatum for which industry players are providing services. Out of these three, NRD and ERD are diagnosed more commonly and are more severe. ERD can lead to the damage of soft tissue in which the lower legs angle outward. Moreover, NRD can produce stress on the posterior structure of the soft tissues of the knee.

Which Methods are Widely Available for Diagnosis of Genu Recurvatum?

“Rising Adoption of Magnetic Resonance Imaging (MRI), X-rays, and Other Methods”

Magnetic Resonance Imaging (MRI), X-rays, and some other diagnostic methods are opted for by healthcare professionals to diagnose genu recurvatum among people, based on requirements and urgency. But, the accuracy of these methods needs to be ensured during the diagnosis procedure.

Key Market Players

Leading companies in the genu recurvatum market are investing in various R&D activities and strengthening their supply chain management system. They are investing at a significant rate to offer more advanced and qualitative treatment solutions. Respective governing bodies implemented certain rules and regulations to ensure minimal environmental impacts. The supply of quality products is also ensured by these players.

DePuy Synthes Companies, Globus Medical, Inc., Medtronic Plc, NuVasive, Inc., Smith & Nephew Plc, Zimmer Inc., and Stryker Corporation are key suppliers of genu recurvatum treatment solutions, which are further contributing to market revenue. These players are investing significantly to offer more effective solutions to patients and healthcare providers.

Segmentation of Genu Recurvatum Industry Research

• By Type :

  • External Rotatory Deformity (ERD)
  • Non-rotatory Deformity (NRD)
  • Internal Rotatory Deformity (IRD)

• By Diagnosis :

  • Magnetic Resonance Imaging (MRI)
  • X-rays
  • Others

• By Treatment :

  • Orthoses
  • Physical Therapy
  • Surgery
  • Bracing

• By End User :

  • Hospitals
  • Clinics
  • Others

• By Region :

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa